[25]
Daiichi first isolated levofloxacin and the (+)-enantiomer of ofloxacin, in April 1985, using Process A. In April 1985, antimicrobial testing revealed that levofloxacin had about twice the activity of ofloxacin. In comparison the (+)-isomer had only between 1/8th to 1/100th the activity of levofloxacin.